Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1)

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 594-599

  MacChia, Gabriella ^a   Morganti, Alessio G ^a,b   Deodato, Francesco ^a   Cilla, Savino ^a   Lucidi, Alessandro ^a   Massaccesi, Mariangela ^a   Scambia, Giovanni ^b   Valentini, Vincenzo ^b   Cellini, Numa ^b   Ferrandina, Gabriella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Concomitant boost radiotherapy; Frozen section analysis; Locally advanced cervical cancer; Preoperative chemoradiation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; BLOOD TOXICITY; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONCOMITANT BOOST RADIOTHERAPY; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DIGESTIVE SYSTEM INJURY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENTEROCOLITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LOCALLY ADVANCED UTERINE CERVIX CARCINOMA; LUMBAR SPINE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOCELE; MICROSCOPY; NAUSEA; OVERALL SURVIVAL; PATHOLOGICAL COMPLETE RESPONSE; PELVIS LYMPH NODE METASTASIS; PELVIS LYMPHADENECTOMY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADICAL HYSTERECTOMY; SKIN TOXICITY; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT DISEASE; UROGENITAL TRACT TOXICITY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84861185212     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.008     Document Type: Conference Paper

References (45)

1. C. McNeil New standard of care for cervical cancer sets stage for next questions J Natl Cancer Inst 91 1999 500 501
2. H.M. Keys, B. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 15 1999 1154 1161
3. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer N Engl J Med 15 1999 1137 1143
4. C.W. Whitney, W. Sause, and W.N. Bundt Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study J Clin Oncol 17 1999 1339 1348
5. P.G. Rose, B.N. Bundy, and Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 15 1999 1144 1153
6. W.A. Peters, P.Y. Liu, and R.J. Barrett Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1614
7. Neoadjuvant Chemotherapy For Cervical Cancer Meta-Analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials Eur J Cancer 39 2003 2470 2486
8. M. Jurado, R. Martinez-Monge, and J. Garcia-Foncillas Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery ±/- intraoperative electron beam radiotherapy in locally advanced cervical cancer Gynecol Oncol 74 1999 30 37
9. M. Distefano, A. Fagotti, and G. Ferrandina Preoperative chemoradiotherapy in locally advanced cervical cancer: long term outcome and complications Gynecol Oncol 99 2005 S166 S170
10. G. Ferrandina, F. Legge, and A. Fagotti Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures Gynecol Oncol 107 2007 S127 S132
11. J.M. Classe, P. Rauch, and J.F. Rodier Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) Gynecol Oncol 102 2006 523 529
12. S. Motton, G. Houvenaeghel, and M. Delannes Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy Int J Gynecol Cancer 20 2010 268 275
13. C. Touboul, C. Uzan, and A. Mauguen Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer Oncologist 15 2010 405 415
14. G. Ferrandina, P.A. Margariti, and D. Smaniotto Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery Gynecol Oncol 119 2010 404 410
15. D. Nguyen, A. de la Rochefordiere, and L. Chauveine Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998 Cancer Radiother 6 2002 201 208
16. G. Houvenaegel, L. Lelievre, and L. Gonzague-Casabianca Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma Gynecol Oncol 100 2006 338 343
17. S. Mancuso, D. Smaniotto, P. Benedetti Panici, B. Favale, S. Greggi, and R. Manfredi Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma Gynecol Oncol 78 2000 324 328
18. G. Macchia, G. Ferrandina, F. Legge, F. Deodato, V. Ruggieri, and D. Lorusso Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1) Am J Clin Oncol 33 2010 577 582
19. N. Cellini, D. Smaniotto, G. Scambia, S. Luzi, M. Balducci, and G. Ferrandina Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study Am J Clin Oncol 31 3 2008 280 284
20. G. Macchia, G. Ferrandina, F. Deodato, V. Ruggieri, M. Massaccesi, and V. Salutari Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1) Gynecol Oncol 118 2 2010 128 133
21. G. Ferrandina, A. Lucidi, A. Paglia, G. Corrado, G. Macchia, and L. Tagliaferri Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications Eur J Surg Oncol 38 3 2012 238 244
22. G. Ferrandina, G. Mantegna, M. Petrillo, G. Fuoco, L. Venditti, and S. Terzano Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study Gynecol Oncol 124 3 2012 389 394
23. B.M. Beadle, A. Jhingran, and S.S. Yom Patterns of regional recurrence after definitive radiotherapy for cervical cancer Int J Radiat Oncol Biol Phys 76 2010 1396 1403
24. P.J. Eifel, K. Winter, and M. Morris Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880
25. C. Capirci, C. Polico, and G. Mandoliti Dislocation of small bowel volume within box pelvic treatment fields, using new "up down table" device Int J Radiat Oncol Biol Phys 51 2001 465 473
26. B. Lengelé, and P. Scalliet Anatomical bases for the radiological delineation of lymph node areas. Part III: pelvis and lower limbs Radiother Oncol 92 2009 22 33
27. M.S. Piver, F. Rutledge, and J.P. Smith Five classes of extended hysterectomy for women with cervical cancer Obstet Gynecol 44 1974 265 272
28. D. Chassagne, P. Sismondi, and J.C. Horiot A glossary for reporting complications of treatment in gynecological cancers Radiother Oncol 26 1993 195 202
29. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
30. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
31. G.F. Zannoni, V.G. Vellone, and A. Carbone Morphological effects of radiochemotherapy on cervical carcinoma: a morphological study of 50 cases of hysterectomy specimens after neoadjuvant treatment Int J Gynecol Pathol 27 2 2008 Apr 274 281
32. R. Simon Optimal two stage design for phase II clinical trials Control Clin Trials 10 1989 1 10
33. F.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations Am J Stat Assoc 53 1958 457 481
34. C. Touboul, C. Uzan, A. Mauguen, S. Gouy, A. Rey, and P. Pautier Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer Gynecol Obstet Fertil 39 5 2011 274 280
35. C. Touboul, C. Uzan, A. Mauguen, S. Gouy, A. Rey, and P. Pautier Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer] J Gynecol Obstet Biol Reprod (Paris) 39 8 2010 624 631
36. E.J. Hall The oxygen effect and reoxygenation E.J. Hall, Radiobiology for the Radiobiologist 1988 Lippincott Philadelphia 137 160
37. J.C. Dimopoulos, R. Pötter, S. Lang, E. Fidarova, P. Georg, W. Dörr, and C. Kirisits Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy Radiother Oncol 93 2 2009 311 315
38. R. Pötter, P. Georg, J.C.A. Dimopoulos, M. Grimm, D. Berger, and N. Nesvacil Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer Radiother Oncol 100 2011 116 123
39. H.M. Keys, B.N. Bundy, F.B. Stehman, T. Okagaki, D.G. Gallup, and A.F. Burnett Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group Gynecol Oncol 89 3 2003 343 353
40. Y.T. Huang, C.C. Wang, C.S. Tsai, C.H. Lai, T.C. Chang, and H.H. Chou Long-term outcome and prognostic factors for adenocarcinoma/ adenosquamouscarcinoma of cervix after definitive radiotherapy Int J Radiat Oncol Biol Phys 80 2 2011 429 436
41. J.H. Hong, C.S. Tsai, and C.C. Wang Comparison of clinical behaviours and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix Chang Gung Med J 23 2000 396 404
42. P.J. Eifel, T.W. Burke, M. Morris, and T.L. Smith Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma Gynecol Oncol 59 1995 38 44
43. K.E. Kjorstad, and B. Bond Stage I adenocarcinoma of the cervix: metastatic potential and patterns of dissemination Am J Obstet Gynecol 150 1984 297 299
44. H.M. Moyses, C.P. Morrow, and L.I. Muderspach Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma Am J Clin Oncol 19 1996 433 438
45. C.C. Chen, J.C. Lin, J.S. Jan, S.C. Ho, and L. Wang Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer Gynecol Oncol 122 2011 9 13